You are viewing the site in preview mode
Skip to main content
| |
Kappa
|
CI 95%
|
|---|
|
Non-enhancement
|
|
Mosaic architecture
|
0.763
|
0.545–0.981
|
|
Intralesional fat
|
0.893
|
0.777–1.000
|
|
Intratumor hemorrhage
|
0.816
|
0.569–1.000
|
|
Iso/Hyper-intense SI (T1WI)
|
0.876
|
0.740–1.000
|
|
T2-DW mismatch
|
0.703
|
0.390–1.000
|
|
Morphology (T2WI)
|
0.871
|
0.775–0.966
|
|
Enhancement without HBP
|
|
AP hyper-enhancement
|
0.876
|
0.741–1.000
|
|
Washout
|
0.800
|
0.657–0.943
|
|
Rim enhancement
|
0.749
|
0.561–0.936
|
|
Capsule enhancement
|
0.844
|
0.718–0.970
|
|
AP halo sign
|
0.760
|
0.582–0.937
|
|
HBP
| | |
|
HBP high uptake
|
0.926
|
0.826–1.000
|
|
HBP halo sign
|
0.857
|
0.664–1.000
|
|
HBP morphology
|
0.951
|
0.894–1.000
|
|
HBP spicule sign
|
0.876
|
0.741–1.000
|
|
HBP brush sign
|
0.858
|
0.704–1.000
|
- k = 0.00–0.20, poor agreement; k = 0.21–0.40, fair agreement; k = 0.41–0.60, moderate agreement; k = 0.61–0.80, good agreement; k = 0.81–1.00, excellent agreement. T1WI, T1-weighted; AP, arterial phase; T2-DW: T2-weighted and diffusion-weighted imaging; T2WI, T2-weighted; HBP, hepatobiliary phase
